Pharmacokinetic Study of ABT-126 in Healthy Volunteers

A Study to Investigate the Process by Which ABT-614 is Absorbed, Distributed, Metabolized and Eliminated in Humans

NCT00959816 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics and Safety of ABT-493 and/or ABT-530 in Subjects With Normal and Impaired Hepatic Function

NCT02296905 ·Status: COMPLETED ·Phase: PHASE1

A Study Designed to Evaluate the Pharmacokinetic Profile of Abiraterone

NCT04295161 ·Status: COMPLETED ·Phase: PHASE1

A Pharmacokinetic Study of Abiraterone Acetate in Patients With Severe Hepatic Impairment Compared to Patients With Normal Hepatic Function

NCT01516047 ·Status: COMPLETED ·Phase: PHASE1

Clinical Trial to Evaluate Pharmacokinetic Interaction of ATB-1011 and ATB-1012 in Healthy Adult Volunteers

NCT04856969 ·Status: COMPLETED ·Phase: PHASE1

A Pharmacokinetics Study of AF-130 in Healthy Subjects

NCT02652936 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics and Safety of ABT-493 and ABT-530 in Subjects With Normal and Impaired Renal Function

NCT02442258 ·Status: COMPLETED ·Phase: PHASE1

Clinical Trial to Compare Pharmacokinetics After Administration of ATB-101 or Co-administration of ATB-1011 and ATB-1012

NCT05017987 ·Status: COMPLETED ·Phase: PHASE1

Effects of Metabolic Enzymes and Transporter Gene Polymorphisms on the Pharmacokinetics and Metabolism of Oral Abiraterone Acetate in Healthy Chinese Adults

NCT04735913 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

Pharmacokinetics (Drug Levels in Blood) of BMS-986165 When Taken as Various Solid Tablet Prototypes by Healthy Participants

NCT04249284 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess Injection Comfort of Two Formulations of ATX-101

NCT01320761 ·Status: COMPLETED ·Phase: PHASE1

Absorption, Metabolism, Excretion and Absolute Bioavailability

NCT03250039 ·Status: COMPLETED ·Phase: PHASE1

Pilot Study of AVT16 in Healthy Adult Subjects

NCT06400719 ·Status: COMPLETED ·Phase: PHASE1

A Phase I, Open-Label Trial to Assess the Absorption, Metabolism, and Excretion of (14C)-OPC-61815 in Healthy Male Japanese Subjects

NCT04182958 ·Status: COMPLETED ·Phase: PHASE1

Absolute Bioavailability and Metabolism Study of CORT118335 in Healthy Male Participants

NCT03878264 ·Status: COMPLETED ·Phase: PHASE1

Safety and Pharmacokinetics Study of Multiple Ascending Doses of BTA-C585 in Healthy Volunteers

NCT02668367 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Drug Levels, Safety, and Tolerability of BMS-986036 in Participants With Normal Liver Function and Participants With Moderate and Severe Liver Impairment

NCT04634149 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of Oral Capsule in Healthy Japanese vs. Caucasian Subjects

NCT03198624 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Mass Balance of [14C] ABBV-903 in Healthy Male Participants Following Single Oral Dose Administration

NCT05995366 ·Status: COMPLETED ·Phase: PHASE1

Lipid and Adipokine Profiles Following Subcutaneous Injection of ATX-101 Into Abdominal Fat Tissue

NCT01319916 ·Status: COMPLETED ·Phase: PHASE1

AMAP102 - Safety, Tolerability and Pharmacokinetics in Healthy Subjects

NCT00995605 ·Status: TERMINATED ·Phase: PHASE1

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Single and Multiple Oral Dose of TAK-418 in Healthy Female Participants

NCT03501069 ·Status: TERMINATED ·Phase: PHASE1

Open-Label Pharmacokinetic Study of Final Formulations of ATX-101

NCT01632917 ·Status: COMPLETED ·Phase: PHASE1

A Single-dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of BMS-986263 in Participants With Varying Degrees of Liver Impairment

NCT04225936 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Drug Levels, Physical and Chemical Changes, and Removal of BMS-986196 in Healthy Male Participants

NCT05981963 ·Status: COMPLETED ·Phase: PHASE1